Clinical Trials Directory

Trials / Completed

CompletedNCT05616767

Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
83 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The long-term objective of the parent study is "to reduce the effects of OPCa through secondary prevention (i.e., early detection, diagnosis and treatment referral)." Consistent with this, this supplement will test HPV-related interventions tailored for Sexual Minority Men (SMM). Acceptability, feasibility and preliminary effectiveness of a smart-phone delivered Oropharyngeal Cancer (OPCA) self-assessment tool will be assessed. Given that homosexuality is stigmatized and criminalized in Tanzania, and that cell phone use is the key way SMM communicate in Tanzania, a self-assessment screening cell phone intervention holds particular promise for SMM in Tanzania but warrants separate evaluation.

Conditions

Interventions

TypeNameDescription
OTHERTraining on self-screening and HPV vaccination administrationParticipants will be taught how to do self-screening for HPV-associated cancers using Training on self-screening and HPV vaccination administration. They will also be given HPV vaccination series.

Timeline

Start date
2022-11-30
Primary completion
2023-04-25
Completion
2023-04-25
First posted
2022-11-15
Last updated
2023-12-14

Locations

1 site across 1 country: Tanzania

Source: ClinicalTrials.gov record NCT05616767. Inclusion in this directory is not an endorsement.